Elevated levels of TMAO, which is linked to Aβ accumulation, tau aggregation, and synaptic damage through mitochondrial impairment and superoxide production within neurons and glia, have been observed in individuals with AD and aged mice101. The gene discussed is MAPT; the disease is Alzheimer disease.